Event Type
Disclosure
Mandatory
Variant
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 23, 2026, Envoy Medical, Inc. (the “Company”) r
Other Events On February 24, 2026, the Company issued a press release regarding the confirmation of regarding Nasdaq compliance. A copy of the press release is
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Envoy Medical, Inc. Press Release, dated February 24, 2026. 104 Cover Page Inter